Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Fortress Biotech (FBIO) over the last 10 years, with Q3 2025 value amounting to $2.4 million.

  • Fortress Biotech's Change in Receivables rose 17537.06% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 9823.09%. This contributed to the annual value of -$4.5 million for FY2024, which is 6434.55% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Change in Receivables is $2.4 million, which was up 17537.06% from -$2.8 million recorded in Q2 2025.
  • Fortress Biotech's Change in Receivables' 5-year high stood at $8.0 million during Q1 2022, with a 5-year trough of -$10.4 million in Q2 2023.
  • For the 5-year period, Fortress Biotech's Change in Receivables averaged around -$254315.8, with its median value being -$51000.0 (2022).
  • Examining YoY changes over the last 5 years, Fortress Biotech's Change in Receivables showed a top increase of 1417058.82% in 2023 and a maximum decrease of 1053855.42% in 2023.
  • Fortress Biotech's Change in Receivables (Quarter) stood at -$8.5 million in 2021, then surged by 99.4% to -$51000.0 in 2022, then surged by 14170.59% to $7.2 million in 2023, then crashed by 110.41% to -$747000.0 in 2024, then skyrocketed by 423.29% to $2.4 million in 2025.
  • Its Change in Receivables was $2.4 million in Q3 2025, compared to -$2.8 million in Q2 2025 and $8.0 million in Q1 2025.